| |
| |
|
| Insider
Information: |
Kirk Randal J |
| Relationship: |
10% Owner |
| City: |
Radford |
| State: |
VA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
3,684,697 |
|
|
Indirect Shares
|
67,796,291 |
|
|
| Direct
Value |
$162,038,028 |
|
|
|
Indirect Value
|
$374,282,250 |
|
|
| Total
Shares |
71,480,988 |
|
|
| Total
Value |
$536,320,277 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
14
|
0
|
|
Stock
price went up :
|
6
|
0
|
| Stock
price went down : |
8
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 46.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Clinical Data Inc |
CLDA |
Director, 10% Owner |
2011-04-12 |
0 |
2011-04-12 |
0 |
Premium* |
|
|
Halozyme Therapeutics Inc |
HALO |
10% Owner |
2018-08-28 |
3,562,388 |
2018-08-28 |
6,629,464 |
Premium* |
|
|
Precipio Inc |
PRPO |
10% Owner |
2012-02-03 |
0 |
2018-08-28 |
27,151 |
Premium* |
|
|
Precigen Inc |
PGEN |
|
|
0 |
2024-05-02 |
51,557,665 |
Premium* |
|
|
Alaunos Therapeutics |
TCRT |
Director, 10% Owner |
2015-12-31 |
122,309 |
2015-12-31 |
9,570,094 |
Premium* |
|
|
Aquabounty Technologies, Inc. |
AQB |
10% Owner |
2020-02-13 |
0 |
2020-12-17 |
11,917 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
271 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 10 of 11
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2015-01-27 |
4 |
B |
$27.00 |
$15,000,012 |
I/I |
555,556 |
5,483,957 |
2.64 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • • |
2021-06-03 |
4 |
A |
$0.00 |
$0 |
I/I |
566,388 |
989,252 |
0 |
- |
|
| PGEN |
Precigen Inc |
Executive Chairman |
• • • |
2020-03-19 |
4 |
B |
$1.87 |
$1,098,311 |
I/I |
579,664 |
10,091,637 |
2.64 |
% |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2003-11-10 |
4 |
A |
$0.00 |
$0 |
D/D |
615,050 |
1,048,191 |
|
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2016-05-31 |
4 |
A |
$0.00 |
$0 |
I/I |
705,379 |
19,711 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2008-06-23 |
4 |
B |
$5.58 |
$4,154,573 |
I/I |
713,232 |
1,271,423 |
2.25 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2011-08-09 |
4 |
B |
$5.88 |
$4,341,386 |
I/I |
738,331 |
738,331 |
2.25 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2018-08-22 |
4 |
S |
$17.49 |
$13,675,099 |
I/I |
(781,881) |
2,430,247 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2016-05-31 |
4 |
A |
$0.00 |
$0 |
I/I |
782,184 |
21,858 |
0 |
- |
|
| PGEN |
Precigen Inc |
Executive Chairman |
• • • |
2020-08-11 |
4 |
B |
$4.50 |
$3,638,331 |
I/I |
808,518 |
218,459 |
2.64 |
% |
|
| PRPO |
Precipio Inc |
10% Owner |
– – • |
2017-08-28 |
4 |
A |
$0.00 |
$0 |
I/I |
813,482 |
271,824 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2008-03-19 |
4 |
B |
$5.80 |
$5,142,570 |
I/I |
886,650 |
5,064,196 |
2.25 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2018-01-19 |
4 |
B |
$12.50 |
$12,500,000 |
I/I |
1,000,000 |
7,782,622 |
2.64 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • • |
2022-10-06 |
4 |
A |
$0.00 |
$0 |
I/I |
1,028,089 |
1,015,604 |
0 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2008-09-26 |
4 |
A |
$16.50 |
$18,000,003 |
I/I |
1,090,744 |
24,240 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2016-05-31 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,196,077) |
0 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2008-03-20 |
4 |
B |
$6.06 |
$7,704,901 |
I/I |
1,264,657 |
6,328,853 |
2.25 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2017-12-29 |
4 |
A |
$11.33 |
$14,686,410 |
I/I |
1,288,632 |
886,491 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2016-05-31 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,326,320) |
0 |
0 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2003-11-10 |
4 |
A |
$0.00 |
$0 |
I/I |
1,411,600 |
112,890 |
|
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2014-12-31 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,679,578) |
0 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2013-08-13 |
4 |
A |
$0.00 |
$1,501,600 |
I/I |
1,696,140 |
76,611 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2013-08-13 |
4 |
A |
$0.00 |
$1,579,760 |
I/I |
1,880,737 |
73,668 |
0 |
- |
|
| PRPO |
Precipio Inc |
10% Owner |
– – • |
2017-06-08 |
4 |
S |
$1.00 |
$1,975,000 |
I/I |
(1,975,000) |
786,613 |
0 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2007-07-17 |
4 |
B |
$22.00 |
$49,500,000 |
I/I |
2,250,000 |
2,250,000 |
2.25 |
- |
|
271 Records found
|
|
Page 10 of 11 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
